<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635692"><TermName>AC-TH regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen,  and sequential AC/Taxol-Trastuzumab regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722833" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;AC-TH regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722834" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen AC-TH&quot;" language="es" id="_4"/><SpanishTermName>régimen AC-TH</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura de una quimioterapia combinada que se usa para tratar el cáncer de mama.   Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin) y ciclofosfamida, seguidas de tratamiento con paclitaxel (Taxol) y trastuzumab (Herceptin).   También se llama AC-T-T, régimen AC-T-T,  y régimen AC/Taxol-Trastuzumab en secuencia.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished></GlossaryTerm>
